Acute Pancreatitis Caused by Tirzepatide

医学 急性胰腺炎 胰腺炎 不利影响 呕吐 恶心 重症监护医学 内科学 胃肠病学
作者
Nur Mando,Erica S Thomson,Matthew Fowler,Lillian Short,Nora Gillen
出处
期刊:Cureus [Cureus, Inc.]
卷期号:16 (12): e76007-e76007 被引量:14
标识
DOI:10.7759/cureus.76007
摘要

Glucagon-like peptide-1 (GLP-1) receptor agonists, including tirzepatide (Mounjaro), are widely used to manage type 2 diabetes mellitus (T2DM) and obesity. While gastrointestinal side effects are common, acute pancreatitis remains a rare but significant complication. Limited evidence exists on the risks associated with switching between GLP-1 agonists, emphasizing the need for clinical awareness. We present a 59-year-old male with T2DM, hyperlipidemia, and hypertension, who was recently transitioned from semaglutide (Ozempic) to tirzepatide (Mounjaro). He presented with acute epigastric pain, nausea, and vomiting two days after initiating tirzepatide. Laboratory findings revealed elevated lipase levels (847 U/L), leukocytosis, and diagnostic imaging confirming acute pancreatitis with other causes ruled out. Supportive care improved symptoms initially, but the clinical course was complicated by fevers prompting repeat imaging, revealing worsening pancreatitis with colonic involvement and pleural effusion. The patient was treated with empiric antibiotics and supportive measures, resulting in resolution of symptoms. Tirzepatide was discontinued, with a follow-up arranged for glycemic management. Acute pancreatitis is a rare but documented adverse effect of GLP-1 agonists, with limited cases reported in the literature. Switching between GLP-1 agonists may increase the risk of adverse effects, especially if appropriate dose titration protocols are not followed. This case highlights the recognition of acute pancreatitis as a potential adverse effect of GLP-1 agonists when initiating or transitioning GLP-1 therapies and following titration protocols to help avoid this complication. GLP-1 agonists, including tirzepatide, offer significant therapeutic benefits for T2DM and obesity but carry risks of rare adverse effects like acute pancreatitis. Greater awareness, careful dose adjustments, and vigilant monitoring are essential to optimizing patient safety. Further research is needed to elucidate the safety profile of switching between GLP-1 agonists to guide clinical practice and improve patient outcomes.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zyy发布了新的文献求助10
2秒前
怕孤独的柠檬完成签到 ,获得积分10
2秒前
3秒前
4秒前
4秒前
5秒前
凝歆完成签到 ,获得积分10
6秒前
6秒前
内向的小凡完成签到,获得积分0
6秒前
xzp完成签到,获得积分10
7秒前
科研工作者TW47JXX5完成签到,获得积分20
7秒前
WU_JIABIN发布了新的文献求助10
8秒前
9秒前
勤恳的新之完成签到,获得积分10
10秒前
10秒前
柚子完成签到 ,获得积分10
10秒前
njw完成签到,获得积分10
11秒前
笛子完成签到,获得积分10
11秒前
Hello的应助被jc哥采纳,获得10
11秒前
雪雪发布了新的文献求助10
11秒前
岳老师发布了新的文献求助10
12秒前
12秒前
海上森林的一只猫完成签到 ,获得积分10
13秒前
wenz01完成签到,获得积分10
13秒前
外向初蓝完成签到,获得积分10
13秒前
田园完成签到,获得积分10
13秒前
lm发布了新的文献求助10
14秒前
新的心跳完成签到,获得积分10
14秒前
Lincoln完成签到,获得积分10
16秒前
大力迎丝完成签到,获得积分10
18秒前
安详慕卉完成签到,获得积分10
18秒前
英姑的应助被67采纳,获得10
18秒前
19秒前
19秒前
19秒前
20秒前
20秒前
鞑靼完成签到,获得积分10
20秒前
爆米花的应助被lm采纳,获得10
20秒前
树叶有专攻完成签到,获得积分0
21秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175157
求助须知:如何正确求助?哪些是违规求助? 9566955
关于积分的说明 21789278
捐赠科研通 7769593
什么是DOI,文献DOI怎么找? 3431836
关于科研通互助平台的介绍 2556078
邀请新用户注册赠送积分活动 2477241